Sales Slip at Walgreen
Though the firm struck a deal with Express Scripts, Walgreen continues to struggle. We aren’t interested in the shares, despite its strong dividend-growth profile.
Exclusive Analysis for the Discerning Investor
Though the firm struck a deal with Express Scripts, Walgreen continues to struggle. We aren’t interested in the shares, despite its strong dividend-growth profile.
Though coming in better than expected on the top and bottom lines, Nike’s first quarter results can best be described as mixed. We think the company’s competitive position remains strong, but the stock is fairly priced.
RIM slows its cash burn and essentially breaks even on a cash flow basis. The results are certainly a positive, but we aren’t fans of the company.
Valero looks to exit its retail business.
Discover reported strong third-quarter results in spite of higher legal expenses.
During the past several months, Blackberry 10 has been delayed several times, and it may eventually fail. But let’s dig into the beleaguered company.
We discuss the power of a rare 10 on our Valuentum Buying Index.
Chinese hotel chain 7 Days Group may be acquired for a price roughly equal to our fair value estimate.
Let’s take a look at recent developments at the company.
Carnival reported better than expected results as cruise demand continues to recover. We think shares are expensive.